anti-CD38/IGF-1 R bispecific scFv antibody (I'Rom Group)

N/A

Report date: 2025/01/26 18:41:04

Base Information

Drug Nameanti-CD38/IGF-1 R bispecific scFv antibody (I'Rom Group)
Drug Alias Nameanti-[CD38 + IGF-1 R] Bs scFv Ab (GeneTry)anti-CD38/IGF-1 R bispecific scFv antibody (GeneTry)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionInsulin-like growth factor I receptor modulatorsLymphocyte differentiation antigen CD38 modulators
TargetsInsulin-like growth factor I receptorLymphocyte differentiation antigen CD38
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeneTry Inc
China Registration ClassN/A

Develop Information

Active CompaniesI'rom Group Co Ltd
Inactive CompaniesGeneTry Inc
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A